Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Collexis Holdings was a leading developer of semantic search and knowledge discovery software specifically designed for the life sciences and academic research sectors. The company's proprietary technology utilized natural language processing to create "Fingerprints" of scientific text, allowing for the identification of trends, experts, and collaborative networks. Its flagship products included the BiomedExperts social network and various expert profiling tools used by global pharmaceutical companies, government agencies, and academic institutions. In 2010, Collexis was acquired by Elsevier to enhance its SciVal suite of research management tools and improve its data analytics capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Collexis Holdings.